» Articles » PMID: 38957749

Annual Assessment of Surveillance Reports Submitted in 2024 in the Context of Commission Delegated Regulation (EU) 2018/772

Overview
Journal EFSA J
Date 2024 Jul 3
PMID 38957749
Authors
Affiliations
Soon will be listed here.
Abstract

This report comprises the 14th assessment of the surveillance scientific reports, provided by Finland, Ireland, United Kingdom (Northern Ireland) and Norway on their respective surveillance programmes. Every year since 2012, EFSA presents the assessment to the European Commission in which the sampling strategy, data collection and detection methods used by these countries are evaluated. More specifically, the surveillance programmes of these four countries are evaluated by checking the information submitted by each of them and verifying that the technical requirements are fulfilled as laid down in Commission Delegated Regulation (EU) 2018/772 of 21 November 2017 supplementing Regulation (EU) No 576/2013 of the European Parliament and of the Council with regard to preventive health measures for the control of infection in dogs, and repealing Delegated Regulation (EU) No 1152/2011. The information is divided into four different categories for assessment: the type and sensitivity of the detection method, the selection of the target population, the sampling strategy and the methodology. For each category, the main aspects that need to be considered in order to accomplish the technical requirements of the legislation are checked against compliance of several criteria. The countries participating in this surveillance (Finland, Ireland, the United Kingdom (Northern Ireland) and Norway) succeeded in the fulfilment of the technical legal requirements foreseen in Commission Delegated Regulation (EU) 2018/772 concerning these four different categories. None of the four countries recorded positive samples in the 12-month reporting period.

Citing Articles

The European Union One Health 2023 Zoonoses report.

EFSA J. 2024; 22(12):e9106.

PMID: 39659847 PMC: 11629028. DOI: 10.2903/j.efsa.2024.9106.

References
1.
Tamarozzi F, Deplazes P, Casulli A . Reinventing the Wheel of Echinococcus granulosus sensu lato Transmission to Humans. Trends Parasitol. 2020; 36(5):427-434. DOI: 10.1016/j.pt.2020.02.004. View

2.
Mihmanli M, Idiz U, Kaya C, Demir U, Bostanci O, Omeroglu S . Current status of diagnosis and treatment of hepatic echinococcosis. World J Hepatol. 2016; 8(28):1169-1181. PMC: 5055586. DOI: 10.4254/wjh.v8.i28.1169. View

3.
Trachsel D, Deplazes P, Mathis A . Identification of taeniid eggs in the faeces from carnivores based on multiplex PCR using targets in mitochondrial DNA. Parasitology. 2007; 134(Pt 6):911-20. DOI: 10.1017/S0031182007002235. View

4.
Zancanaro G . Annual assessment of surveillance reports submitted in 2021 in the context of Commission Delegated Regulation (EU) 2018/772. EFSA J. 2021; 19(11):e06945. PMC: 8600939. DOI: 10.2903/j.efsa.2021.6945. View

5.
Kapel C, Torgerson P, Thompson R, Deplazes P . Reproductive potential of Echinococcus multilocularis in experimentally infected foxes, dogs, raccoon dogs and cats. Int J Parasitol. 2005; 36(1):79-86. DOI: 10.1016/j.ijpara.2005.08.012. View